These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19940894)

  • 21. Scott Gottlieb steps down from US FDA leadership.
    Jaffe S
    Lancet; 2019 Mar; 393(10176):1086-1087. PubMed ID: 30957743
    [No Abstract]   [Full Text] [Related]  

  • 22. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 23. We really need to talk: adapting FDA processes to rapid change.
    Lykken S
    Food Drug Law J; 2013; 68(4):357-99, i. PubMed ID: 24552079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 21st century cures act: Opportunities and challenges.
    Sarpatwari A; Kesselheim AS
    Clin Pharmacol Ther; 2015 Dec; 98(6):575-7. PubMed ID: 26264909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2006 people to watch. Double trouble?
    Science; 2006 Jan; 311(5757):35. PubMed ID: 16400129
    [No Abstract]   [Full Text] [Related]  

  • 26. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy.
    Abraham J; Davis C
    Soc Sci Med; 2005 Sep; 61(5):881-92. PubMed ID: 15955393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The FDA in the 21st Century: How Is the FDA Responding to the New World? A Focus on Heart Failure Devices.
    Hillebrenner M; Zuckerman B; Fiuzat M; Stockbridge N; Califf R
    JACC Heart Fail; 2016 Dec; 4(12):974-977. PubMed ID: 27908396
    [No Abstract]   [Full Text] [Related]  

  • 29. Politics could hamper FDA reform.
    Fox JL
    Biotechnology (N Y); 1995 Nov; 13(11):1156. PubMed ID: 9678917
    [No Abstract]   [Full Text] [Related]  

  • 30. Discussion: Is the FDA in need of a major change in the way it regulates?
    Molenberghs G
    Biostatistics; 2017 Jul; 18(3):408-410. PubMed ID: 28633316
    [No Abstract]   [Full Text] [Related]  

  • 31. An FDA Commissioner for the 21st Century.
    Chandra A; Sachs RE
    N Engl J Med; 2017 Apr; 376(15):e31. PubMed ID: 28402241
    [No Abstract]   [Full Text] [Related]  

  • 32. Incoming chief to tackle woes of US food and drug agency.
    Wadman M
    Nature; 2009 Mar; 458(7236):271. PubMed ID: 19295575
    [No Abstract]   [Full Text] [Related]  

  • 33. Reading our lips: the history of lipstick regulation in Western seats of power.
    Schaffer SE
    Food Drug Law J; 2007; 62(1):165-225. PubMed ID: 17444030
    [No Abstract]   [Full Text] [Related]  

  • 34. A proposal for FDA reform.
    Miller HI
    Nat Rev Drug Discov; 2002 Aug; 1(8):642-8. PubMed ID: 12402504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulation of biotechnologies: four recommendations.
    Fox D
    Hastings Cent Rep; 2008; 38(2):1 p following 56. PubMed ID: 18457229
    [No Abstract]   [Full Text] [Related]  

  • 36. ORA's role at FDA headquarters and in the field for product recalls.
    Whetstone SN
    Food Drug Law J; 1998; 53(3):513-6. PubMed ID: 10346723
    [No Abstract]   [Full Text] [Related]  

  • 37. Discussion: New directions for the FDA in the 21st century.
    Lo AW
    Biostatistics; 2017 Jul; 18(3):404-407. PubMed ID: 28633313
    [No Abstract]   [Full Text] [Related]  

  • 38. In need of rehab.
    Nature; 2005 Oct; 437(7060):789-90. PubMed ID: 16208322
    [No Abstract]   [Full Text] [Related]  

  • 39. A Safer Food Future, Now.
    Schlosser E
    Consum Rep; 2016 May; 81(5):50-5. PubMed ID: 27197315
    [No Abstract]   [Full Text] [Related]  

  • 40. The safety of medical devices and the role of the FDA.
    Pillar B
    Nurs Econ; 1991; 9(4):284-6. PubMed ID: 1922433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.